Search

everythinglearnresearchcommunity

for

Search:↓

Particle properties affect drug retention and release in minoxidil foams, with lipid nanoparticles having higher loading capacity.

The document concludes that PK/PD modeling is important for determining the safe and effective dosages of drugs.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

Activin B helps start and grow hair follicles in mice.

Hair transplantation, especially follicular unit micrografting, was the top treatment for male pattern baldness, with a focus on natural results and ongoing improvements in both surgical and medical management.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

The document concludes that identifying the cause of eyebrow and eyelash loss is key to treating it and improving quality of life.

The polyherbal hair gel is effective against fungal infections and helps nourish hair and prevent graying.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

The emu oil emulsion with minoxidil was better at promoting hair growth than the commercial product.

Topical sensitizers have mixed success in treating alopecia areata.

Treating scalp issues in hair-pulling disorder helps hair regrow and reduces itch.

Injecting a person's own skin cells back into their skin is a promising, safe, and affordable treatment for skin disorders.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Squaric acid dibutylester effectively treats alopecia areata.

Dutasteride is the most effective hair loss treatment after 24 weeks, but finasteride leads to the most hair growth after 48 weeks.

Minoxidil can help transgender males grow facial hair before starting testosterone therapy.

Skin-derived stem cells grow faster and are easier to obtain than hair follicle stem cells, but both can become various cell types.

Personalized treatments for hair loss are becoming more effective by using genetic information.

More personalized and effective treatments for androgenetic alopecia are needed.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Low-dose oral minoxidil effectively promotes hair growth but has associated risks.